ARCHIVES

Why Shouldn’t Scientific Issues Be Discussed In Open Meetings? Editorial

This article is from The Cancer Letter archive.

Vol. 15 No. 43 | November 10, 1989

Download PDF Visit The Full Archive

Related Articles

In Brief: FDA Oncological Drugs Advisory Committee Gets New Charter, Georgetown’s Schein Is Chairman

October 13, 1978

Chart Show 1980 Budget Breakown By Mechanisms, Research Programs, Compare Them With Previous Years

June 9, 1978

DCPC Board Approves Concepts Of Six New RFAs Totaling $9.3 Million A Year

May 11, 1984

Changes In Labels Of Anticancer Drugs Suggested; Response Is Slow

October 8, 1976

In Congress: Senate Bill Offers 13% Increase For NCI; house Provides 9%

October 8, 1999

In Brief: Paul Rambaut Leaving NCI For NATO Position; Niederhuber New Cancer Commission Chairman

December 9, 1988